Compstatin: a C3-targeted complement inhibitor reaching its prime for bedside intervention-Reference-Cited by-同舟云学术

Compstatin: a C3-targeted complement inhibitor reaching its prime for bedside intervention

Published:2015-03-09 Issue:4 Volume:45 Page:423-440
ISSN:0014-2972
Container-title:European Journal of Clinical Investigation
language:en
Short-container-title:Eur J Clin Invest

Author:

Mastellos Dimitrios C.¹,Yancopoulou Despina²,Kokkinos Petros²,Huber-Lang Markus³,Hajishengallis George⁴,Biglarnia Ali R.⁵,Lupu Florea⁶,Nilsson Bo⁷,Risitano Antonio M.⁸,Ricklin Daniel⁹,Lambris John D.⁹

Affiliation:

1. Division of Biodiagnostic Sciences and Technologies; INRASTES, National Center for Scientific Research ‘Demokritos’; Aghia Paraskevi Attikis Greece

2. Amyndas Pharmaceuticals; Glyfada Greece

3. Department of Traumatology; Center of Surgery; University of Ulm; Ulm Germany

4. Department of Microbiology; School of Dental Medicine; University of Pennsylvania; Philadelphia PA USA

5. Department of Surgical Sciences; Section of Transplantation Surgery; Uppsala University; Uppsala Sweden

6. Cardiovascular Biology Research Program; Oklahoma Medical Research Foundation; Oklahoma City OK USA

7. Department of Immunology, Genetics and Pathology; Uppsala University; Uppsala Sweden

8. Hematology, Department of Clinical Medicine and Surgery; Federico II University of Naples; Naples Italy

9. Department of Pathology and Laboratory Medicine; University of Pennsylvania; Philadelphia PA USA

Funder

National Institutes of Health

European Community’s Seventh Framework Programme

Publisher

Wiley

Subject

Clinical Biochemistry,Biochemistry,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/eci.12419/fullpdf

Reference110 articles.

1. New approaches in data integration for systems chemical biology;Seoane;Curr Top Med Chem,2013

2. Progress and trends in complement therapeutics;Ricklin;Adv Exp Med Biol,2013

3. CMAP: complement Map Database;Yang;Bioinformatics,2013

4. Complement: a key system for immune surveillance and homeostasis;Ricklin;Nat Immunol,2010

5. Complement in immune and inflammatory disorders: pathophysiological mechanisms;Ricklin;J Immunol,2013

Cited by 185 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Navigating the Complement Pathway to Optimize PNH Treatment with Pegcetacoplan and Other Currently Approved Complement Inhibitors;International Journal of Molecular Sciences;2024-08-31

2. The complement model disease paroxysmal nocturnal hemoglobinuria;European Journal of Immunology;2024-08-05

3. The Complement System as a Therapeutic Target in Retinal Disease;Medicina;2024-06-05

4. Moss-produced human complement factor H with modified glycans has an extended half-life and improved biological activity;Frontiers in Immunology;2024-05-10

5. Deciphering the monocyte-targeting mechanisms of PEGylated cationic liposomes by investigating the biomolecular corona;International Journal of Pharmaceutics;2024-05